Skip to content

Clinical trials

Phase 3 Leiomyosarcoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Phase: Phase 3 Country / region: Canada Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20151
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Alliance for Clinical Trials in Oncology1
Children's Oncology Group1
Eli Lilly and Company1
Polaris Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma7
Liposarcoma6
Sarcoma6
Histiocytoma, Malignant Fibrous5
Fibrosarcoma4
Hemangiosarcoma4
Neurofibrosarcoma4
Sarcoma, Synovial4
Sarcoma, Alveolar Soft Part3
Rhabdomyosarcoma2

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.